Annals of the Rheumatic Diseases · 2018 · 13 citations · 0 references
PharmacyInternal MedicinePharmacologyClinical PharmacologyPharmacovigilanceRheumatologyAdverse Drug Event DetectionAdverse Drug Event ReportingAdverse Drug Reaction MonitoringDrug Safety MonitoringPost-marketing Safety SurveillanceRheumatoid ArthritisInterim AnalysisJanus Kinase Inhibitor TherapyPost-market Drug Safety AnalysisPost-marketing Drug Safety SurveillancePost-marketing SurveillancePost-marketing Surveillance AnalysisPost-marketing Surveillance DataSerious Adverse Events